{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:45:33Z","timestamp":1792075533814,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","award":["ZY01_07 and 2611T0812"],"award-info":[{"award-number":["ZY01_07 and 2611T0812"]}],"id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["2024-3-034"],"award-info":[{"award-number":["2024-3-034"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06322-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:54:56Z","timestamp":1784602496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual residual risk of lipid and inflammation: a prospective analysis of RCII on hypertension incidence and cardiovascular prognosis in Chinese and UK populations"],"prefix":"10.1186","volume":"26","author":[{"given":"Lerui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8207-7367","authenticated-orcid":false,"given":"Boda","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"6322_CR1","first-page":"e41","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 heart disease and stroke statistics: A report of us and global data from the american heart association. Circulation. 2025;151:e41\u2013660.","journal-title":"Circulation"},{"key":"6322_CR2","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1186\/s12889-025-25553-4","volume":"25","author":"Z Cheraghi","year":"2025","unstructured":"Cheraghi Z, Azmi-Naei B, Cheraghi P, Doosti-Irani A. The global prevalence of uncontrolled hypertension: a systematic review and meta-analysis. BMC Public Health. 2025;25:4259.","journal-title":"BMC Public Health"},{"key":"6322_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/jamacardio.2022.3926","volume":"8","author":"PH Stone","year":"2023","unstructured":"Stone PH, Libby P, Boden WE. Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis: a narrative review. JAMA Cardiol. 2023;8:192\u2013201.","journal-title":"JAMA Cardiol"},{"key":"6322_CR4","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jacc.2021.08.051","volume":"78","author":"RS Rosenson","year":"2021","unstructured":"Rosenson RS, Shaik A, Song W. New therapies for lowering triglyceride-rich lipoproteins: Jacc focus seminar 3\/4. J Am Coll Cardiol. 2021;78:1817\u201330.","journal-title":"J Am Coll Cardiol"},{"key":"6322_CR5","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.jacc.2020.10.029","volume":"76","author":"JR Burnett","year":"2020","unstructured":"Burnett JR, Hooper AJ, Hegele RA. Remnant cholesterol and atherosclerotic cardiovascular disease risk. J Am Coll Cardiol. 2020;76:2736\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"6322_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M, et al. The nlrp3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett. 2023;28:51.","journal-title":"Cell Mol Biol Lett"},{"key":"6322_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7:131.","journal-title":"Signal Transduct Target Ther"},{"key":"6322_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/nu18020205","volume":"18","author":"H Chen","year":"2026","unstructured":"Chen H, Wu JY, Yan H, Gao J, Li C, Xie JH, et al. Association of remnant cholesterol inflammatory index with stroke, heart disease and all-cause mortality across cardiovascular-kidney-metabolic syndrome stages 0-3: a national cohort study. Nutrients. 2026;18:205.","journal-title":"Nutrients"},{"key":"6322_CR9","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1111\/bph.12616","volume":"171","author":"F Bian","year":"2014","unstructured":"Bian F, Yang X, Zhou F, Wu PH, Xing S, Xu G, et al. C-reactive protein promotes atherosclerosis by increasing ldl transcytosis across endothelial cells. Br J Pharmacol. 2014;171:2671\u201384.","journal-title":"Br J Pharmacol"},{"key":"6322_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-023-01826-3","volume":"22","author":"L Yang","year":"2023","unstructured":"Yang L, Yue Q, Fang F, Zhang Y, Liu P, Zhang Z, et al. Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular disease. Cardiovasc Diabetol. 2023;22:96.","journal-title":"Cardiovasc Diabetol"},{"key":"6322_CR11","doi-asserted-by":"publisher","first-page":"117141","DOI":"10.1016\/j.atherosclerosis.2023.05.010","volume":"379","author":"T Doi","year":"2023","unstructured":"Doi T, Langsted A, Nordestgaard BG. Dual elevated remnant cholesterol and c-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality. Atherosclerosis. 2023;379:117141.","journal-title":"Atherosclerosis"},{"key":"6322_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.0000000637","volume":"36","author":"SE Claudel","year":"2025","unstructured":"Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative incidence of mortality associated with cardiovascular-kidney-metabolic (CKM) syndrome. J Am Soc Nephrol. 2025;36:1343\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"6322_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jare.2024.12.015","volume":"76","author":"J Chen","year":"2025","unstructured":"Chen J, Wu Q, Liu H, Hu W, Zhu J, Ji Z, et al. Predictive value of remnant cholesterol inflammatory index for stroke risk: evidence from the China health and retirement longitudinal study. J Adv Res. 2025;76:543\u201352.","journal-title":"J Adv Res"},{"key":"6322_CR14","doi-asserted-by":"publisher","first-page":"1603907","DOI":"10.3389\/fendo.2025.1603907","volume":"16","author":"F Wang","year":"2025","unstructured":"Wang F, Li Q. Association between residual cholesterol and vulnerable non-culprit lesions progressing to major adverse cardiovascular events. Front Endocrinol (Lausanne). 2025;16:1603907.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6322_CR15","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1161\/ATVBAHA.123.319297","volume":"43","author":"EP Navarese","year":"2023","unstructured":"Navarese EP, Vine D, Proctor S, Grzelakowska K, Berti S, Kubica J, et al. Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a mendelian randomization study. Arterioscler Thromb Vasc Biol. 2023;43:e373\u201380.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6322_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-90-481-8622-8_8","volume":"51","author":"YI Miller","year":"2010","unstructured":"Miller YI, Choi SH, Fang L, Tsimikas S. Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis. Subcell Biochem. 2010;51:229\u201351.","journal-title":"Subcell Biochem"},{"key":"6322_CR17","first-page":"e44202","volume":"15","author":"X Chen","year":"2023","unstructured":"Chen X, Li LH. Remnant cholesterol, a valuable biomarker for assessing arteriosclerosis and cardiovascular risk: a systematic review. Cureus. 2023;15:e44202.","journal-title":"Cureus"},{"key":"6322_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2019.02.019","volume":"284","author":"A Lin","year":"2019","unstructured":"Lin A, Nerlekar N, Rajagopalan A, Yuvaraj J, Modi R, Mirzaee S, et al. Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography. Atherosclerosis. 2019;284:24\u201330.","journal-title":"Atherosclerosis"},{"key":"6322_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41440-024-01609-7","volume":"47","author":"A Kunimura","year":"2024","unstructured":"Kunimura A, Miura K. Is remnant cholesterol a new therapeutic target for preventing hypertension? Hypertens Res. 2024;47:1227\u20138.","journal-title":"Hypertens Res"},{"key":"6322_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","volume":"79","author":"L Liberale","year":"2022","unstructured":"Liberale L, Badimon L, Montecucco F, L\u00fcscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: Jacc review topic of the week. J Am Coll Cardiol. 2022;79:837\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"6322_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, et al. Cd36 coordinates nlrp3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. 2013;14:812\u201320.","journal-title":"Nat Immunol"},{"key":"6322_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/jrms.jrms_695_21","volume":"27","author":"N Balashkevich","year":"2022","unstructured":"Balashkevich N, Kazymov M, Syzdykbayev M, Adylova A. Molecular basis of acute coronary syndrome. J Res Med Sci. 2022;27:40.","journal-title":"J Res Med Sci"},{"key":"6322_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","volume":"21","author":"TJ Guzik","year":"2024","unstructured":"Guzik TJ, Nosalski R, Maffia P, Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol. 2024;21:396\u2013416.","journal-title":"Nat Rev Cardiol"},{"key":"6322_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis. Circ Res. 2016;119:91\u2013112.","journal-title":"Circ Res"},{"key":"6322_CR25","doi-asserted-by":"publisher","first-page":"101072","DOI":"10.1016\/j.xcrm.2023.101072","volume":"4","author":"Y Shen","year":"2023","unstructured":"Shen Y, Dong Z, Fan F, Li K, Zhu S, Dai R, et al. Targeting cytokine-like protein FAM3D lowers blood pressure in hypertension. Cell Rep Med. 2023;4:101072.","journal-title":"Cell Rep Med"},{"key":"6322_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","volume":"94","author":"S Patel","year":"2017","unstructured":"Patel S, Rauf A, Khan H, Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother. 2017;94:317\u201325.","journal-title":"Biomed Pharmacother"},{"key":"6322_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13098-025-01753-1","volume":"17","author":"G Li","year":"2025","unstructured":"Li G, Luo C, Ge T, He K, Zhang M, Hu J, et al. Evaluating the impact of metabolic indicators and scores on cardiovascular events using machine learning. Diabetol Metab Syndr. 2025;17:180. https:\/\/doi.org\/10.1186\/s13098-025-01753-1.","journal-title":"Diabetol Metab Syndr"},{"key":"6322_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.toxlet.2025.07.1414","volume":"411","author":"G Li","year":"2025","unstructured":"Li G, Zhang T, He K, Zhang M, Hu J, Ge T, et al. Deciphering the influence of heavy metals on adverse cardiovascular events using machine learning. Toxicol Lett. 2025;411:101. https:\/\/doi.org\/10.1016\/j.toxlet.2025.07.1414.","journal-title":"Toxicol Lett"},{"key":"6322_CR29","doi-asserted-by":"publisher","first-page":"4639334","DOI":"10.1155\/2024\/4639334","volume":"2024","author":"G Li","year":"2024","unstructured":"Li G, Lin D, Fan X, Peng B. Exploring hypertrophic cardiomyopathy biomarkers through integrated bioinformatics analysis: uncovering novel diagnostic candidates. Cardiol Res Pract. 2024;2024:4639334. https:\/\/doi.org\/10.1155\/2024\/4639334.","journal-title":"Cardiol Res Pract"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06322-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:02:53Z","timestamp":1792072973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06322-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6322"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06322-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHARLS and UKB studies were conducted in accordance with the Declaration of Helsinki. The CHARLS protocol was approved by the Ethical Review Committee of Peking University (IRB00001052-11015). The UKB study received ethical approval from the North West Multi-centre Research Ethics Committee (11\/NW\/0382). Written informed consent was obtained from all participants prior to data collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"923"}}